Get the Stockscreener App
0.3912
0.82%
-0.0006
Envveno Medical Corporation stock is traded at $0.3912, with a volume of 254.56K.
It is down -0.82% in the last 24 hours and down -42.71% over the past month.
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
See More
Previous Close:
$0.3918
Open:
$0.387
24h Volume:
254.56K
Relative Volume:
0.43
Market Cap:
$7.91M
Revenue:
-
Net Income/Loss:
$-24.05M
P/E Ratio:
-0.182
EPS:
-2.15
Net Cash Flow:
$-17.78M
1W Performance:
+1.33%
1M Performance:
-42.71%
6M Performance:
-88.83%
1Y Performance:
-87.17%
1-Day Range:
$0.3701
$0.4027
1-Week Range:
$0.352
$0.419
52-Week Range:
$0.3017
$5.62
Envveno Medical Corporation Stock (NVNO) Company Profile
Name
Envveno Medical Corporation
Sector
Industry
Phone
949-261-2900
Address
70 DOPPLER, IRVINE
Compare NVNO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
0.3912 | 7.84M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
125.34 | 218.05B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.04 | 144.86B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
365.55 | 139.34B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
102.00 | 130.75B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.81 | 49.78B | 5.88B | 1.34B | 799.60M | 2.3489 |
Envveno Medical Corporation Stock (NVNO) Latest News
Is enVVeno Medical Corporation (5HJ) stock a good hedge against inflation2025 Retail Activity & Fast Gain Swing Trade Alerts - Newser
How enVVeno Medical Corporation (5HJ) stock reacts to stronger dollarJuly 2025 Action & Target Return Focused Picks - Newser
Will enVVeno Medical Corporation (5HJ) stock profit from fiscal stimulus2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
Why enVVeno Medical Corporation stock is favored by top institutionsEntry Point & Stock Market Timing Techniques - Newser
Is enVVeno Medical Corporation (5HJ) stock undervalued by metricsMarket Sentiment Report & Consistent Income Trade Recommendations - Newser
How enVVeno Medical Corporation stock compares to industry benchmarks2025 Market Trends & Fast Entry Momentum Trade Alerts - Newser
Is enVVeno Medical Corporation (5HJ) stock resilient in recession scenariosTrade Entry Report & AI Forecasted Entry/Exit Points - Newser
Can enVVeno Medical Corporation (5HJ) stock deliver double digit returnsWeekly Stock Summary & Free Expert Verified Stock Movement Alerts - Newser
Is enVVeno Medical Corporation (5HJ) stock worth holding before Fed meetingTrade Exit Summary & Weekly Breakout Stock Alerts - Newser
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment - Courier & Press
enVVeno Medical (NASDAQ: NVNO) adds reverse stock split vote to 2025 meeting - Stock Titan
Midday Stock Roundup: Tilly’s, indie Semiconductor Up - Orange County Business Journal
The growth track for enVVeno Medical Corporation (NVNO) has changed recently - Setenews
Why analysts maintain buy rating on enVVeno Medical Corporation (5HJ) stockJuly 2025 Chart Watch & Low Drawdown Investment Ideas - Newser
Published on: 2025-12-02 03:25:08 - Newser
Published on: 2025-12-02 02:21:59 - Newser
Can Pearl Polymers Limited Escape Recent Bear ChannelEarnings Miss Alerts & Free Trading Signals to Sharpen Your Edge - earlytimes.in
enVVeno Medical (NASDAQ:NVNO) & Nihon Kohden (OTCMKTS:NHNKY) Head-To-Head Comparison - Defense World
Midday Stock Roundup: Netlist Up on Public Interest Comment - Orange County Business Journal
What drives enVVeno Medical Corporation 5HJ stock priceMerger & Acquisition Updates & Fast Profit Trading Ideas - earlytimes.in
Can enVVeno Medical Corporation stock hit record highs againJuly 2025 Trade Ideas & Daily Stock Trend Reports - BỘ NỘI VỤ
EnVVeno Medical to Participate in a Live Virtual Investor CEO Connect Segment - MarketScreener
Published on: 2025-11-27 15:32:39 - BỘ NỘI VỤ
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - The Coloradoan
enVVeno Medical (NASDAQ: NVNO) schedules CEO investor webcast with live Q&A on Dec 3 - Stock Titan
Taking on analysts’ expectations and winning: enVVeno Medical Corporation (NVNO) - Setenews
enVVeno Medical Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Fall River Herald News
Insider Buyers Lose US$294k As enVVeno Medical Sheds US$1.9m - simplywall.st
Insider Buyers Lose Additional US$294k As enVVeno Medical Dips To US$6.5m - Yahoo Finance
enVVeno Medical (NASDAQ:NVNO) Trading 1.9% Higher – Still a Buy? - Defense World
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve - Online Athens
enVVeno Medical Amends Quorum Requirement for Meetings - MSN
enVVeno Medical updates bylaws to revise stockholder quorum requirement By Investing.com - Investing.com Nigeria
enVVeno Medical updates bylaws to revise stockholder quorum requirement - Investing.com India
[8-K] enVVeno Medical Corp Reports Material Event | NVNO SEC FilingForm 8-K - Stock Titan
Will enVVeno Medical Corporation (5HJ) stock profit from AI boomMarket Activity Summary & Consistent Profit Focused Trading Strategies - newser.com
How institutional buying supports enVVeno Medical Corporation stockJuly 2025 Technicals & AI Powered Buy/Sell Recommendations - newser.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Published on: 2025-11-20 05:33:35 - newser.com
Why enVVeno Medical Corporation stock remains resilientJuly 2025 Trends & Intraday High Probability Alerts - newser.com
Why analysts upgrade enVVeno Medical Corporation stock - newser.com
Envveno Medical Corporation Stock (NVNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.36%
1.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):